In order to make its drug discovery research even more efficient, Mochida Pharmaceutical is promoting collaborative drug discovery research and development with academia and venture and biotech companies, by introducing drug candidates/targets or state-of-art technologies.
Since 2019, the company is managing its MOIRe (Mochida Open Innovation Research) programme and is now inviting researchers and research representatives affiliated with public research institutions, universities, etc. to submit proposals for collaborative research relating to drug candidates or targets for intractable, rare, or refractory diseases focusing on therapeutic modalities of stem cell drugs, oligonucleotide therapeutics or gene therapy. Application deadline 31 July 2023.
Published: June 2023
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026
